High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy forHelicobacter pyloriInfections-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy forHelicobacter pyloriInfections

Published:2014-04-03 Issue:4 Volume:19 Page:319-322
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Attumi Taraq A.¹,Graham David Y.¹

Affiliation:

1. Michael E. DeBakey Veterans Affairs Medical Center; RM 3A-320 (111D), 2002 Holcombe Boulevard and Baylor College of Medicine Houston TX 77030 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hel.12126/fullpdf

Reference34 articles.

1. Helicobacter pylori

2. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study;Unge;Scand J Gastroenterol Suppl,1989

3. Treatment of Helicobacter pylori infection: a review of the world literature;van der Hulst;Helicobacter,1996

4. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta- analysis;Bazzoli;Helicobacter,1998

5. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study;Zagari;Gut,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis;BMC Infectious Diseases;2024-09-11

2. The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan;Journal of Microbiology, Immunology and Infection;2024-08

3. Detection of H. pylori IgA and IgG in serum and saliva collected from health care individuals suffering from gastrointestinal disorders with correlation to individual hygiene and parasitic infections;2024-07-16

4. Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection;Microorganisms;2023-12-19

5. Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial;BMC Gastroenterology;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3